LOADING
Comparing Mastercard Inc (MA) and Thermo Fisher Scientific (TMO) across the Financials and Health Care sectors. This side-by-side analysis covers price, valuation multiples, profitability, growth, dividends, and risk metrics to help investors evaluate these two stocks.
| Metric | MA | TMO |
|---|---|---|
| Price | -- | -- |
| Change Today | +0.00% | +0.00% |
| Market Cap | $465.2B | $195.7B |
| P/E Ratio | 31.5 | 29.7 |
| Forward P/E | 26.6 | 21.3 |
| PEG Ratio | 1.66 | 1.95 |
| EPS | $16.53 | $17.75 |
| Revenue Growth (YoY) | 17.6% | 7.2% |
| Profit Margin | 45.7% | 15.0% |
| Return on Equity | 209.9% | 13.0% |
| Dividend Yield | 0.61% | 0.33% |
| Beta | 0.83 | 0.97 |
| 52-Week High | $599.05 | $643.35 |
| 52-Week Low | $479.68 | $384.44 |
| Volume | -- | -- |
Mastercard Inc is the larger company by market capitalization. Thermo Fisher Scientific trades at a lower P/E ratio, suggesting it may offer better value relative to earnings. Mastercard Inc offers a higher dividend yield for income investors. Mastercard Inc has stronger profit margins. Both stocks should be evaluated in the context of your investment goals, risk tolerance, and portfolio diversification needs.